Neural Regeneration Research (Jan 2024)

Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes

  • Carmen Hierro-Bujalance,
  • Monica Garcia-Alloza

DOI
https://doi.org/10.4103/1673-5374.385865
Journal volume & issue
Vol. 19, no. 6
pp. 1189 – 1190

Abstract

Read online

No abstracts available.